• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从晚期乳头状浆液性卵巢癌中鉴定出一种潜在的卵巢癌干细胞基因表达谱。

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.

机构信息

Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2012;7(1):e29079. doi: 10.1371/journal.pone.0029079. Epub 2012 Jan 17.

DOI:10.1371/journal.pone.0029079
PMID:22272227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260150/
Abstract

Identification of gene expression profiles of cancer stem cells may have significant implications in the understanding of tumor biology and for the design of novel treatments targeted toward these cells. Here we report a potential ovarian cancer stem cell gene expression profile from isolated side population of fresh ascites obtained from women with high-grade advanced stage papillary serous ovarian adenocarcinoma. Affymetrix U133 Plus 2.0 microarrays were used to interrogate the differentially expressed genes between side population (SP) and main population (MP), and the results were analyzed by paired T-test using BRB-ArrayTools. We identified 138 up-regulated and 302 down-regulated genes that were differentially expressed between all 10 SP/MP pairs. Microarray data was validated using qRT-PCR and17/19 (89.5%) genes showed robust correlations between microarray and qRT-PCR expression data. The Pathway Studio analysis identified several genes involved in cell survival, differentiation, proliferation, and apoptosis which are unique to SP cells and a mechanism for the activation of Notch signaling is identified. To validate these findings, we have identified and isolated SP cells enriched for cancer stem cells from human ovarian cancer cell lines. The SP populations were having a higher colony forming efficiency in comparison to its MP counterpart and also capable of sustained expansion and differentiation in to SP and MP phenotypes. 50,000 SP cells produced tumor in nude mice whereas the same number of MP cells failed to give any tumor at 8 weeks after injection. The SP cells demonstrated a dose dependent sensitivity to specific γ-secretase inhibitors implicating the role of Notch signaling pathway in SP cell survival. Further the generated SP gene list was found to be enriched in recurrent ovarian cancer tumors.

摘要

鉴定癌症干细胞的基因表达谱可能对理解肿瘤生物学具有重要意义,并为针对这些细胞的新型治疗方法的设计提供依据。本研究报告了从高级别晚期乳头状浆液性卵巢腺癌患者的新鲜腹水分离的侧群中鉴定出的潜在卵巢癌干细胞基因表达谱。使用 Affymetrix U133 Plus 2.0 微阵列来检测侧群(SP)和主群(MP)之间差异表达的基因,使用 BRB-ArrayTools 对配对 T 检验的结果进行分析。我们鉴定了 10 对 SP/MP 之间差异表达的 138 个上调基因和 302 个下调基因。使用 qRT-PCR 对微阵列数据进行验证,17/19(89.5%)个基因的微阵列和 qRT-PCR 表达数据之间具有很强的相关性。Pathway Studio 分析鉴定了一些涉及细胞存活、分化、增殖和凋亡的基因,这些基因是 SP 细胞所特有的,并且鉴定出 Notch 信号通路的激活机制。为了验证这些发现,我们已经从人卵巢癌细胞系中鉴定和分离了富含癌症干细胞的 SP 细胞。与 MP 相比,SP 群体的集落形成效率更高,并且能够持续扩增和分化为 SP 和 MP 表型。50,000 个 SP 细胞在裸鼠中产生肿瘤,而相同数量的 MP 细胞在注射后 8 周内未能产生任何肿瘤。SP 细胞对特定 γ-分泌酶抑制剂表现出剂量依赖性敏感性,表明 Notch 信号通路在 SP 细胞存活中起作用。进一步发现生成的 SP 基因列表在复发性卵巢癌肿瘤中富集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/247bf3275347/pone.0029079.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/612e3c5c9a1e/pone.0029079.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/998b8df68ef8/pone.0029079.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/8980be2f3209/pone.0029079.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/9beb7af77a89/pone.0029079.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/503abdec0d6b/pone.0029079.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/247bf3275347/pone.0029079.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/612e3c5c9a1e/pone.0029079.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/998b8df68ef8/pone.0029079.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/8980be2f3209/pone.0029079.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/9beb7af77a89/pone.0029079.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/503abdec0d6b/pone.0029079.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c276/3260150/247bf3275347/pone.0029079.g006.jpg

相似文献

1
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.从晚期乳头状浆液性卵巢癌中鉴定出一种潜在的卵巢癌干细胞基因表达谱。
PLoS One. 2012;7(1):e29079. doi: 10.1371/journal.pone.0029079. Epub 2012 Jan 17.
2
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.卵巢浆液性低恶性潜能、低级别及高级别肿瘤的表达谱分析
Cancer Res. 2005 Nov 15;65(22):10602-12. doi: 10.1158/0008-5472.CAN-05-2240.
3
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.具有微乳头状特征的低恶性潜能肿瘤在分子水平上与卵巢低级别浆液性癌相似。
Gynecol Oncol. 2010 Apr;117(1):9-17. doi: 10.1016/j.ygyno.2010.01.006. Epub 2010 Feb 1.
4
Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.晚期乳头状浆液性卵巢癌的全基因组表达谱揭示了激活的信号通路。
Oncogene. 2004 Oct 21;23(49):8065-77. doi: 10.1038/sj.onc.1207959.
5
[Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].[卵巢癌细胞系中干细胞的鉴定与特性分析及其耐药性检测]
Zhonghua Fu Chan Ke Za Zhi. 2015 Jun;50(6):452-7.
6
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.原发性卵巢浆液性乳头状肿瘤和正常卵巢上皮中的基因表达谱:卵巢癌诊断和治疗候选分子标志物的鉴定
Int J Cancer. 2004 Oct 20;112(1):14-25. doi: 10.1002/ijc.20408.
7
A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.一种以CD44和prominin-1(CD133)作为选择标记物来分离和鉴定癌症干细胞样细胞的合理方法。
Oncotarget. 2016 Nov 29;7(48):78499-78515. doi: 10.18632/oncotarget.12100.
8
SOX2 expression associates with stem cell state in human ovarian carcinoma.SOX2 表达与人卵巢癌细胞的干细胞状态相关。
Cancer Res. 2013 Sep 1;73(17):5544-55. doi: 10.1158/0008-5472.CAN-12-4177. Epub 2013 Jul 18.
9
Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.吲哚胺2,3-双加氧酶在浆液性卵巢癌细胞的基因表达谱中作为预后不良的标志物。
Clin Cancer Res. 2005 Aug 15;11(16):6030-9. doi: 10.1158/1078-0432.CCR-04-2671.
10
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.卵巢浆液性癌肿瘤活检与短期原代培养之间的差异基因表达谱:用于早期诊断和治疗的新型分子生物标志物的鉴定
Gynecol Oncol. 2006 Nov;103(2):405-16. doi: 10.1016/j.ygyno.2006.03.056. Epub 2006 May 24.

引用本文的文献

1
Detection of Cancer Stem Cells from Patient Samples.从患者样本中检测癌症干细胞。
Cells. 2025 Jan 20;14(2):148. doi: 10.3390/cells14020148.
2
Advances in ovarian tumor stem cells and therapy.卵巢肿瘤干细胞及治疗的研究进展。
Cell Biochem Biophys. 2024 Sep;82(3):1871-1892. doi: 10.1007/s12013-024-01385-8. Epub 2024 Jul 3.
3
The Role of Cancer Stem Cell Markers in Ovarian Cancer.癌症干细胞标志物在卵巢癌中的作用

本文引用的文献

1
Notch signalling in solid tumours: a little bit of everything but not all the time.实体瘤中的 Notch 信号通路:并非无时无刻都在发挥作用,但也并非微不足道。
Nat Rev Cancer. 2011 May;11(5):338-51. doi: 10.1038/nrc3035. Epub 2011 Apr 14.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.从人卵巢上皮癌细胞系中鉴定出癌症干细胞样细胞。
Cancers (Basel). 2023 Dec 20;16(1):40. doi: 10.3390/cancers16010040.
4
GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways.GBA抑制可抑制卵巢癌的生长、存活以及受体酪氨酸激酶AXL介导的信号通路。
Korean J Physiol Pharmacol. 2023 Jan 1;27(1):21-29. doi: 10.4196/kjpp.2023.27.1.21.
5
Ovarian cancer stem cells: Critical roles in anti-tumor immunity.卵巢癌干细胞:在抗肿瘤免疫中的关键作用。
Front Genet. 2022 Nov 10;13:998220. doi: 10.3389/fgene.2022.998220. eCollection 2022.
6
CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells.CDC50A 可能是上皮性卵巢癌起始细胞的新型生物标志物。
BMC Cancer. 2022 Aug 19;22(1):903. doi: 10.1186/s12885-022-09953-y.
7
Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis.通过转录组分析鉴定癌症干细胞在上皮性卵巢癌化疗耐药复发中的作用
J Oncol. 2022 Mar 31;2022:6406122. doi: 10.1155/2022/6406122. eCollection 2022.
8
Transcriptomic Analyses Reveal B-Cell Translocation Gene 2 as a Potential Therapeutic Target in Ovarian Cancer.转录组分析揭示B细胞易位基因2是卵巢癌的一个潜在治疗靶点。
Front Oncol. 2021 Aug 17;11:681250. doi: 10.3389/fonc.2021.681250. eCollection 2021.
9
Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.Krüppel 样因子 9 的缺失通过 Notch1/slug 信号通路促进卵巢癌腹水来源的多细胞球体的干性。
Cancer Sci. 2021 Oct;112(10):4220-4233. doi: 10.1111/cas.15100. Epub 2021 Aug 20.
10
Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.卵巢癌干细胞:特征与在肿瘤发生中的作用。
Adv Exp Med Biol. 2021;1330:151-169. doi: 10.1007/978-3-030-73359-9_10.
Cell Mol Life Sci. 2010 Nov;67(22):3915-25. doi: 10.1007/s00018-010-0420-9. Epub 2010 Jun 12.
4
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.来自具有层级结构的卵巢癌细胞中的 CD24+细胞富含癌症干细胞。
Oncogene. 2010 May 6;29(18):2672-80. doi: 10.1038/onc.2010.35. Epub 2010 Mar 1.
5
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.一种预测晚期卵巢癌预后的基因特征鉴定出一种生存因子:微原纤维相关糖蛋白2。
Cancer Cell. 2009 Dec 8;16(6):521-32. doi: 10.1016/j.ccr.2009.10.018.
6
The role of cancer stem cells and the side population in epithelial ovarian cancer.癌症干细胞和侧群在卵巢上皮性癌中的作用。
Histol Histopathol. 2010 Jan;25(1):113-20. doi: 10.14670/HH-25.113.
7
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.CD133 表达在原发性人卵巢癌中定义了肿瘤起始细胞群体。
Stem Cells. 2009 Dec;27(12):2875-83. doi: 10.1002/stem.236.
8
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.PTEN/PI3K/Akt信号通路调控胶质瘤肿瘤干细胞样细胞的侧群表型及ABCG2活性。
Cell Stem Cell. 2009 Mar 6;4(3):226-35. doi: 10.1016/j.stem.2009.01.007.
9
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.人卵巢癌干细胞的分子表型分析揭示了修复和化疗耐药机制。
Cell Cycle. 2009 Jan 1;8(1):158-66. doi: 10.4161/cc.8.1.7533.
10
The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.卵巢癌细胞的侧群细胞是干扰素-α抗肿瘤作用的主要靶点。
Cancer Res. 2008 Jul 15;68(14):5658-68. doi: 10.1158/0008-5472.CAN-07-6341.